*Correspondence: Neda Roshanravan, [email protected] Dehghan, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
To find out more about it, keep reading
And when hydration feels easy, enjoyable, and convenient, it becomes much simpler to stay consistent
Tirzepatide has the most extensive published literature, with FDA approval, multiple completed Phase 3 trial programs (SURMOUNT, SURPASS), and extensive real-world evidence
Observational analyses and randomized clinical trials consistently report nausea, vomiting, diarrhea, constipation, and abdominal discomfort as the most common symptoms, although the distribution of events varies